← Leaderboards
Bingfang Yan
University Of Cincinnati
$8,901,955
Attributed
$10,777,414
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,777,414 · 11
By mechanism
R01$8,757,861 · 5
R21$1,334,937 · 3
R15$437,475 · 1
R29$215,499 · 1
P20$31,642 · 1
Top collaborators
- Jason T Blackard4 shared
- Jennifer L Brown4 shared
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsDesignEnzymesMetabolismCellsMonitorSamplingStemCarboxylesterase 1Drug MetabolismOrganEnsureFoundationsMedicineProdrugsCarboxylesteraseHepatocyteOriginalityGenesReceptorHydrolysisMolecularCessation Of LifeBase
Grant awards (34)
Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination$697,172
R01 · FY2025 · AA · contact PI
Metabolism-based interactions and organ-targeted delivery of molnupiravir, nirmatrelvir and remdesivir$537,517
R01 · FY2025 · AI · contact PI
Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination$697,172
R01 · FY2024 · AA · contact PI
Metabolism-based interactions and organ-targeted delivery of molnupiravir, nirmatrelvir and remdesivir$479,695
R01 · FY2024 · AI · contact PI
Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination$697,172
R01 · FY2023 · AA · contact PI
Functional connection between the growth factor independence-1b and post-neonatal regulation of biotransformation genes$445,500
R21 · FY2023 · HD · contact PI
Metabolism-based interactions and organ-targeted delivery of molnupiravir, nirmatrelvir and remdesivir$423,312
R01 · FY2023 · AI · contact PI
Circular RNA regulators of common drug-eliminating genes$243,000
R21 · FY2023 · HD · contact PI
Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination$721,672
R01 · FY2022 · AA · contact PI
Circular RNA regulators of common drug-eliminating genes$202,500
R21 · FY2022 · HD · contact PI
Metabolic basis for lipid abnormality with anti-HIV tenofovir prodrugs$243,000
R21 · FY2021 · AI · contact PI
Metabolic basis for lipid abnormality with anti-HIV tenofovir prodrugs$200,937
R21 · FY2020 · AI · contact PI
Biodegradable hollow CUS nanoparticles for photothermal cancer therapy$191,598
R01 · FY2016 · EB · contact PI
Biodegradable hollow CuS nanoparticles for photothermal cancer therapy$113,224
R01 · FY2016 · EB · contact PI
Biodegradable hollow CuS nanoparticles for photothermal cancer therapy$332,571
R01 · FY2015 · EB · contact PI
Signaling of the Pregnane X Receptor$276,300
R01 · FY2015 · GM · contact PI
Signaling of the Pregnane X Receptor$276,300
R01 · FY2014 · GM · contact PI
Interplay between metabolism and FXR activation in scoparone signaling$437,475
R15 · FY2013 · AT · contact PI
Signaling of the Pregnane X Receptor$264,267
R01 · FY2009 · GM · contact PI
Signaling of the Pregnane X Receptor$102,935
R01 · FY2009 · GM · contact PI
Signaling of the Pregnane X Receptor$264,267
R01 · FY2008 · GM · contact PI
Signaling of the Pregnane X Receptor$264,267
R01 · FY2007 · GM · contact PI
Molecular Toxicology of Carboxylesterases$300,567
R01 · FY2006 · ES · contact PI
Signaling of the Pregnane X Receptor$272,160
R01 · FY2006 · GM · contact PI
Molecular Toxicology of Carboxylesterases$307,800
R01 · FY2005 · ES
Molecular Toxicology of Carboxylesterases$307,800
R01 · FY2004 · ES
BRIN: URI: TMSR/FUNCTIONAL GENOMICS &PROTEOMICS SUBCORE$31,642
P20 · FY2004 · RR
Molecular Toxicology of Carboxylesterases$307,800
R01 · FY2003 · ES
SIGNALING OF PREGNANE X RECEPTOR$230,400
R01 · FY2003 · GM
SIGNALING OF PREGNANE X RECEPTOR$230,400
R01 · FY2002 · GM
SIGNALING OF PREGNANE X RECEPTOR$230,400
R01 · FY2001 · GM
MOLECULAR TOXICOLOGY OF PLACENTAL CARBOXYLESTRASE$109,342
R29 · FY2001 · ES
SIGNALING OF PREGNANE X RECEPTOR$231,093
R01 · FY2000 · GM
MOLECULAR TOXICOLOGY OF PLACENTAL CARBOXYLESTRASE$106,157
R29 · FY2000 · ES